Report Detail

Chemical & Material Global Sofosbuvir (CAS 1190307-88-0) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3856162
  • |
  • 23 December, 2019
  • |
  • Global
  • |
  • 105 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Chemical & Material

Description

Scope of the Report:
The worldwide market for Sofosbuvir (CAS 1190307-88-0) is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Sofosbuvir (CAS 1190307-88-0) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Teva Pharmaceutical Industries Ltd
Beijing Kawin Technology Share-holding Co
DEAFARMA
DONG BANG FUTURE TECH & LIFE CO., LTD
Shanghai Haoyuan Chemexpress Co., Ltd
Beaukev Pharma International Pvt.Ltd
Anhui HaiKang Pharmaceutical Co. Ltd
Tecoland
Hangzhou Longshine Bio-Tech Co

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Purity ≥ 98%
Purity < 98%

Market Segment by Applications, can be divided into
Adults Patients
Elderly Patients

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sofosbuvir (CAS 1190307-88-0) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Sofosbuvir (CAS 1190307-88-0), with price, sales, revenue and global market share of Sofosbuvir (CAS 1190307-88-0) in 2017 and 2018.
Chapter 3, the Sofosbuvir (CAS 1190307-88-0) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sofosbuvir (CAS 1190307-88-0) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Sofosbuvir (CAS 1190307-88-0) market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Sofosbuvir (CAS 1190307-88-0) sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Sofosbuvir (CAS 1190307-88-0) Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Purity ≥ 98%
      • 1.2.2 Purity < 98%
    • 1.3 Market Analysis by Applications
      • 1.3.1 Adults Patients
      • 1.3.2 Elderly Patients
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Teva Pharmaceutical Industries Ltd
      • 2.1.1 Business Overview
      • 2.1.2 Sofosbuvir (CAS 1190307-88-0) Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Beijing Kawin Technology Share-holding Co
      • 2.2.1 Business Overview
      • 2.2.2 Sofosbuvir (CAS 1190307-88-0) Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 DEAFARMA
      • 2.3.1 Business Overview
      • 2.3.2 Sofosbuvir (CAS 1190307-88-0) Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 DONG BANG FUTURE TECH & LIFE CO., LTD
      • 2.4.1 Business Overview
      • 2.4.2 Sofosbuvir (CAS 1190307-88-0) Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 DONG BANG FUTURE TECH & LIFE CO., LTD Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Shanghai Haoyuan Chemexpress Co., Ltd
      • 2.5.1 Business Overview
      • 2.5.2 Sofosbuvir (CAS 1190307-88-0) Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Shanghai Haoyuan Chemexpress Co., Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Beaukev Pharma International Pvt.Ltd
      • 2.6.1 Business Overview
      • 2.6.2 Sofosbuvir (CAS 1190307-88-0) Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Beaukev Pharma International Pvt.Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Anhui HaiKang Pharmaceutical Co. Ltd
      • 2.7.1 Business Overview
      • 2.7.2 Sofosbuvir (CAS 1190307-88-0) Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Anhui HaiKang Pharmaceutical Co. Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Tecoland
      • 2.8.1 Business Overview
      • 2.8.2 Sofosbuvir (CAS 1190307-88-0) Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Hangzhou Longshine Bio-Tech Co
      • 2.9.1 Business Overview
      • 2.9.2 Sofosbuvir (CAS 1190307-88-0) Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Sofosbuvir (CAS 1190307-88-0) Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Sofosbuvir (CAS 1190307-88-0) Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Sofosbuvir (CAS 1190307-88-0) Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Sofosbuvir (CAS 1190307-88-0) Market Analysis by Regions

    • 4.1 Global Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 4.3 Europe Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 4.5 South America Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)

    5 North America Sofosbuvir (CAS 1190307-88-0) by Country

    • 5.1 North America Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Country
      • 5.1.1 North America Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 5.3 Canada Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)

    6 Europe Sofosbuvir (CAS 1190307-88-0) by Country

    • 6.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 6.3 UK Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 6.4 France Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 6.5 Russia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 6.6 Italy Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) by Country

    • 7.1 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Country (2014-2019)
    • 7.2 China Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 7.3 Japan Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 7.4 Korea Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 7.5 India Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)

    8 South America Sofosbuvir (CAS 1190307-88-0) by Country

    • 8.1 South America Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Country
      • 8.1.1 South America Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) by Countries

    • 9.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Sofosbuvir (CAS 1190307-88-0) Sales and Growth Rate (2014-2019)

    10 Global Sofosbuvir (CAS 1190307-88-0) Market Segment by Type

    • 10.1 Global Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Sofosbuvir (CAS 1190307-88-0) Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Sofosbuvir (CAS 1190307-88-0) Revenue and Market Share by Type (2014-2019)
    • 10.2 Purity ≥ 98% Sales Growth and Price
      • 10.2.1 Global Purity ≥ 98% Sales Growth (2014-2019)
      • 10.2.2 Global Purity ≥ 98% Price (2014-2019)
    • 10.3 Purity < 98% Sales Growth and Price
      • 10.3.1 Global Purity < 98% Sales Growth (2014-2019)
      • 10.3.2 Global Purity < 98% Price (2014-2019)

    11 Global Sofosbuvir (CAS 1190307-88-0) Market Segment by Application

    • 11.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Market Share by Application (2014-2019)
    • 11.2 Adults Patients Sales Growth (2014-2019)
    • 11.3 Elderly Patients Sales Growth (2014-2019)

    12 Sofosbuvir (CAS 1190307-88-0) Market Forecast (2019-2024)

    • 12.1 Global Sofosbuvir (CAS 1190307-88-0) Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Sofosbuvir (CAS 1190307-88-0) Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Sofosbuvir (CAS 1190307-88-0) Market Forecast (2019-2024)
      • 12.2.2 Europe Sofosbuvir (CAS 1190307-88-0) Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Sofosbuvir (CAS 1190307-88-0) Market Forecast (2019-2024)
      • 12.2.4 South America Sofosbuvir (CAS 1190307-88-0) Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Sofosbuvir (CAS 1190307-88-0) Market Forecast (2019-2024)
    • 12.3 Sofosbuvir (CAS 1190307-88-0) Market Forecast by Type (2019-2024)
      • 12.3.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Sofosbuvir (CAS 1190307-88-0) Market Share Forecast by Type (2019-2024)
    • 12.4 Sofosbuvir (CAS 1190307-88-0) Market Forecast by Application (2019-2024)
      • 12.4.1 Global Sofosbuvir (CAS 1190307-88-0) Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Sofosbuvir (CAS 1190307-88-0) Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Sofosbuvir (CAS 1190307-88-0). Industry analysis & Market Report on Sofosbuvir (CAS 1190307-88-0) is a syndicated market report, published as Global Sofosbuvir (CAS 1190307-88-0) Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Sofosbuvir (CAS 1190307-88-0) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,745.72
      4,118.58
      5,491.44
      3,201.60
      4,802.40
      6,403.20
      539,991.60
      809,987.40
      1,079,983.20
      290,580.00
      435,870.00
      581,160.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report